Skip to content

Study · Not a test of the peptide alone · 2007

2 results

Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.

Demange L, Boeglin D, Moulin A, Mousseaux D, Ryan J, Bergé G, Gagne D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J

Journal of medicinal chemistry22 Mar 2007Cited by 61 (Europe PMC)

PMID17375904 (opens in a new tab)DOI10.1021/jm070024h (opens in a new tab)PepBankPUB-17375904
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Hexarelin.

  1. 01AnimalNot a test of Hexarelin aloneAnimal study (in vivo)Activity measurement

    In rodents, some triazole compounds were identified as potent antagonists of hexarelin-stimulated food intake.

    In plain wordsIn rodents, some new compounds blocked the increase in food intake caused by hexarelin.

    Peptide
    Hexarelin
    Outcome
    DecreaseHexarelin-stimulated food intake
    Study

    rodentsn: not reported in source

    In vivo, rodents
    Outcome group
    Appetite and food intake · Metabolic and weight

    Source sentences

    Summary
    some others were identified as potent hexarelin antagonists in this assay.

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  2. 02AnimalNot a test of Hexarelin aloneAnimal study (in vivo)Activity measurement

    In rodents, compound 21b was a potent in vivo antagonist of hexarelin-stimulated food intake.

    In plain wordsIn rodents, one new compound (21b) blocked the increase in food intake caused by hexarelin.

    Peptide
    Hexarelin
    Outcome
    DecreaseHexarelin-stimulated food intake with compound 21b
    Study

    rodentsn: not reported in source

    In vivo, rodents
    Outcome group
    Appetite and food intake · Metabolic and weight

    Source sentences

    Summary
    as well as a potent in vivo antagonist of hexarelin-stimulated food intake in rodents.

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.